[1] Prior year balances have been restated to reflect the retrospective application of the new revenue recognition accounting standard.
See notes to condensed consolidated financial statements.
[1] Prior year balances have been restated to reflect the retrospective application of the new revenue recognition accounting standard.
See notes to condensed consolidated financial statements.
[1] Prior year balances have been restated to reflect the retrospective application of the new revenue recognition accounting standard.
See notes to condensed consolidated financial statements.
[1] Prior year balances have been restated to reflect the retrospective application of the new revenue recognition accounting standard.
See notes to condensed consolidated financial statements.
The accompanying interim condensed consolidated financial statements have been prepared in conformity with United States (U.S.) generally accepted accounting principles (GAAP) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X, and should be read in conjunction with the Xilinx, Inc. (Xilinx or the Company) consolidated financial statements filed with the U.S. Securities and Exchange Commission (SEC) on Form 10-K for the fiscal year ended March 31, 2018.
The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ending March 30, 2019 or any future period.
Fiscal 2019 and fiscal 2018 are both 52-week years ending on March 30, 2019 and March 31, 2018, respectively.When determining the fair values of assets required and liabilities acquired, management makes significant estimates and assumptions, especially with respect to intangible assets.
•Advanced Products include our most recent product offerings and consist of the Alveo branded boards, UltraScale+, UltraScale and 7-series product families.
•Core Products consist of all other product families."Financial Statements" for information regarding patent litigation.
•market acceptance of our customers' products.
We rely on independent foundries for the manufacture of all of our products and a manufacturing problem or insufficient foundry capacity could adversely affect our operations.
Terms with respect to the volume and timing of wafer production and the pricing of wafers produced by the semiconductor foundries are determined through periodic negotiations with these wafer foundries, which usually result in short-term agreements that do not provide for long-term supply or allocation commitments.
We rely on TSMC, UMC and our other foundries to produce wafers with competitive performance attributes.